Newsroom
Home
Newsroom
-
29 Jul 2024morePublicationsA case series on safety and tolerability of human umbilical cord-derived mesenchymal stem cells on patients in Malaysia
EL837 and EliteGro-Adv. related publication.
-
14 Dec 2022morePublicationsNebulization Therapy with Umbilical Cord Mesenchymal Stem Cell‑Derived Exosomes for COVID‑19 Pneumonia
EL837 and EliteGro-Adv. related publication.
-
31 Oct 2022moreEventsBIO Asia–Taiwan 2023
26 to 30 July 2023, Taipei, Taiwan
Hall 1, Taipei Nangang Exhibition Center (TaiNEX1) -
31 Oct 2022moreEvents2022 Taiwan Healthcare+
1 to 4 December 2022, Taipei, Taiwan
Hall 1, Taipei Nangang Exhibition Center (TaiNEX1) -
20 Apr 2022morePublicationsThree-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia
EL837 and EliteGro-Adv. related publication.
-
20 Apr 2022morePublicationsComparison of senescence-related changes between three- and two-dimensional cultured adipose-derived mesenchymal stem cells
EL837 and EliteGro-Adv. related publication.
-
12 Apr 2022morePublicationsHuman adipose, placenta, and umbilical cord-derived mesenchymal stem cells ameliorate imiquimod-induced psoriatic mice via reducing T cells infiltration
EL837 and EliteGro-Adv. related publication.
-
08 Nov 2021moreEvents2021 Bio Asia-Taiwan Exhibition
Showcasing 650+ biomedical and healthcare companies over 1,600 booths.
A multitude of business opportunities await in the post-pandemic world. -
28 Oct 2021moreEventsBio Asia-Taiwan Exhibition has been rescheduled
Onsite exhibition has been rescheduled to 11/4-7(Thu-Sun), 2021 at TaiNEX 2.
Online exhibition will be two rounds, the first round will be started from 7/19-7/28(Mon-Wed) -
13 Jan 2021morePublicationsA robust platform for expansion and genome editing of primary human natural killer cells
EL837 and EliteGro-Adv. related publication.